{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:15:26Z","timestamp":1784632526618,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/jps.23690","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T17:53:12Z","timestamp":1377539592000},"page":"3957-3965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gastric Pre-Processing Is an Important Determinant of the Ability of Medium-Chain Lipid Solution Formulations to Enhance Oral Bioavailability in Rats"],"prefix":"10.1016","volume":"102","author":[{"given":"Kathy Wai Yu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23690_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jps.23690_bb0010","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0015","doi-asserted-by":"crossref","first-page":"103128","DOI":"10.1016\/S0169-409X(96)00494-2","article-title":"Lipid-based vehicles for the oral delivery of poorly water soluble drugs","volume":"25","author":"Humberstone","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23690_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5085(71)80001-X","article-title":"Lipolytic activity of human gastric and duodenal juice against medium and long chain triglycerides","volume":"60","author":"Cohen","year":"1971","journal-title":"Gastroenterology"},{"key":"10.1002\/jps.23690_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1748-1716.1946.tb00356.x","article-title":"The gastric lipase in man","volume":"11","author":"Schonheyder","year":"1946","journal-title":"Acta Physiol Scand"},{"key":"10.1002\/jps.23690_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-2760(85)90221-8","article-title":"Secretion of human gastric lipase from dispersed gastric glands","volume":"836","author":"DeNigris","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23690_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/62.1.74","article-title":"Dietary-fat modulates gastric lipase activity in healthy humans","volume":"62","author":"Armand","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1002\/jps.23690_bb0040","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s11095-007-9363-8","article-title":"Low dose lipid formulations: Effects on gastric emptying and biliary secretion","volume":"24","author":"Kossena","year":"2007","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.46.5.689","article-title":"The role of long chain fatty acids in regulating food intake and cholecytokinin release in humans","volume":"46","author":"Matzinger","year":"2000","journal-title":"Gut"},{"key":"10.1002\/jps.23690_bb0050","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s11095-009-9906-2","article-title":"In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol\u00ae and Gelucire\u00ae 44\/14","volume":"26","author":"Fernandez","year":"2009","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0021-9673(93)87027-J","article-title":"Reversed-phase highperformance liquid chromatography for evaluating the lipophilicity of pharmaceutical substances with ionization up to log Papp=8","volume":"629","author":"Belsner","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1002\/jps.23690_bb0060","first-page":"412","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-409X(01)00148-X","article-title":"Animal models for the study of intestinal lymphatic drug transport","volume":"50","author":"Edwards","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23690_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jps.23384","article-title":"The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug","volume":"102","author":"Lee","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jps.10329","article-title":"Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs","volume":"92","author":"Kossena","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0731-7085(00)00528-8","article-title":"Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis","volume":"25","author":"Sek","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"10.1002\/jps.23690_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/B:PHAM.0000016282.77887.1f","article-title":"Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations","volume":"21","author":"Kaukonen","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2004.06.013","article-title":"A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs","volume":"99","author":"Kossena","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.23690_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(92)90065-A","article-title":"Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies","volume":"82","author":"Shah","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23690_bb0100","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jps.20039","article-title":"Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine","volume":"93","author":"Porter","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1211\/jpp.62.07.0006","article-title":"Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II","volume":"62","author":"Nguyen","year":"2010","journal-title":"In-vivo evaluation, J Pharm Pharmacol"},{"key":"10.1002\/jps.23690_bb0110","first-page":"G372","article-title":"Characterization of emulsions and lipolysis of dietary lipids in the human stomach","volume":"266","author":"Armand","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1002\/jps.23690_bb0115","first-page":"G172","article-title":"Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum","volume":"34","author":"Armand","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1002\/jps.23690_bb0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/ajcn\/36.5.950","article-title":"Medium-chain triglycerides: An update","volume":"36","author":"Bach","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"10.1002\/jps.23690_bb0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.idairyj.2006.06.015","article-title":"Medium-chain triglycerides","volume":"16","author":"Marten","year":"2006","journal-title":"Int Dairy J"},{"key":"10.1002\/jps.23690_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cis.2010.06.010","article-title":"Sturctured emulsion-based delivery systens: Controlling the digestion and release of lipophilic food components","volume":"159","author":"McClements","year":"2010","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1002\/jps.23690_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1203\/00006450-198405000-00002","article-title":"Fat digestion by lingual lipase: Mechanism of lipolysis in the stomach and upper small intestine","volume":"18","author":"Liao","year":"1984","journal-title":"Pediatr Res"},{"key":"10.1002\/jps.23690_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.83.1.86","article-title":"Gastric lipolysis and fat absorption in preterm infants: Effect of medium-chain triglyceride or long-chain triglyceride-containing formulas","volume":"83","author":"Hamosh","year":"1989","journal-title":"Pediatrics"},{"key":"10.1002\/jps.23690_bb0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbalip.2007.02.009","article-title":"Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol\u00ae, medium chain glycerides and PEG esters","volume":"1771","author":"Fernandez","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23690_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5173(86)90043-8","article-title":"The oral absorption of cefoxitin from oil and emulsion vehicles in rats","volume":"33","author":"Palin","year":"1986","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23690_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5173(92)90374-B","article-title":"Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats","volume":"78","author":"Myers","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23690_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1015993112678","article-title":"Pancreatic lipase-catalyzed hydrolysis of esters of hydroxymethyl phenytoin dissolved in various metabolizable vehicles, dispersed in micellar systems, and in aqueous suspensions","volume":"6","author":"Alvarez","year":"1989","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0165","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/mp300164u","article-title":"Lipid digestion as a trigger for supersaturation: Evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems","volume":"9","author":"Anby","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.23690_bb0170","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/mp300331z","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion","volume":"9","author":"Williams","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.23690_bb0175","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/jps.22226","article-title":"Precipitation of a poorly soluble model drug during in vitro lipolysis: Characterization and dissolution of the precipitate","volume":"99","author":"Sassene","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0180","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jps.2600620918","article-title":"Biopharmaceutics of drugs administered in lipid-containing dosage forms I: GI absorption of griseofulvin from an oil-in-water emulsion in the rat","volume":"62","author":"Carrigan","year":"1973","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23690_bb0185","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11095-006-9054-x","article-title":"Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: Correlation with in vivo data and the relationship to intra-enterocyte processes in rats","volume":"23","author":"Dahan","year":"2006","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23690_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","article-title":"Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behavior of their lipolytic products","volume":"54","author":"Sek","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.23690_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2008.03.021","article-title":"Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs","volume":"129","author":"Dahan","year":"2008","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T19:50:46Z","timestamp":1668628246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915308583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0022354915308583"],"URL":"https:\/\/doi.org\/10.1002\/jps.23690","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastric Pre-Processing Is an Important Determinant of the Ability of Medium-Chain Lipid Solution Formulations to Enhance Oral Bioavailability in Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.23690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Wiley Periodicals, Inc. and the American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}